You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: isolated systolic hypertension increases mortality and morbidity in elderly people and should be treated

https://doi.org/10.1136/ebm.5.5.138

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    (2000) Lancet 355, 865. Staessen JA, Gasowski J, Wang JG, et al. . Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. . . Mar 11;. :. –72..
    OpenUrlCrossRefPubMedWeb of Science

    
 
 QUESTIONS: In elderly people, what are the risks associated with isolated systolic hypertension (≥160 mm Hg with diastolic blood pressure [BP] <95 mm Hg), and what is the magnitude of the benefit associated with treatment?

    Data sources

    Studies were identified from 10 published overviews and 2 reports from trialist collaborations.

    Study selection

    Controlled trials were selected if elderly people with isolated systolic hypertension were enrolled. Trials were excluded if all the study participants had comorbid conditions, such as stroke; if specialised care was compared with routine antihypertensive agents; and if the study was a preliminary evaluation for a larger study.

    Data extraction

    Data were extracted on study quality, patient characteristics, antihypertensive treatment, duration and length of follow up, and outcomes (all cause and cardiovascular mortality, cardiovascular complications, all strokes, and all …

    View Full Text